CTSF expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance
Normal-vs-Primary 4.623600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Stage1
4.811400E-01
Normal-vs-Stage2
4.864400E-01
Normal-vs-Stage3
6.559800E-01
Normal-vs-Stage4
3.737000E-01
Stage1-vs-Stage2
6.079000E-01
Stage1-vs-Stage3
6.587200E-01
Stage1-vs-Stage4
7.601000E-01
Stage2-vs-Stage3
8.999800E-01
Stage2-vs-Stage4
4.938600E-01
Stage3-vs-Stage4
4.903400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Caucasian
4.893600E-01
Normal-vs-AfricanAmerican
2.793700E-02
Normal-vs-Asian
4.956400E-01
Caucasian-vs-AfricanAmerican
1.085960E-01
Caucasian-vs-Asian
8.063000E-01
AfricanAmerican-vs-Asian
3.125200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Male
5.458800E-01
Normal-vs-Female
3.853600E-01
Male-vs-Female
6.620200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Age(21-40Yrs)
3.321600E-01
Normal-vs-Age(41-60Yrs)
3.202000E-01
Normal-vs-Age(61-80Yrs)
5.463800E-01
Normal-vs-Age(81-100Yrs)
6.797600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.631000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.053200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.399400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.902630E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.690020E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.190600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Non Drinker
9.814400E-01
Normal-vs-Daily Drinker
3.704000E-01
Normal-vs-Weekly Drinker
1.795620E-01
Normal-vs-Occasional Drinker
5.107800E-01
Normal-vs-Social Drinker
5.488000E-01
Non Drinker-vs-Daily Drinker
2.377800E-02
Non Drinker-vs-Weekly Drinker
8.376400E-03
Non Drinker-vs-Occasional Drinker
1.277620E-01
Non Drinker-vs-Social Drinker
1.861160E-01
Daily Drinker-vs-Weekly Drinker
5.474000E-01
Daily Drinker-vs-Occasional Drinker
4.247400E-01
Daily Drinker-vs-Social Drinker
7.277600E-01
Weekly Drinker-vs-Occasional Drinker
1.503600E-01
Weekly Drinker-vs-Social Drinker
4.028400E-01
Occasional Drinker-vs-Social Drinker
7.494400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions
Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade)
Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Grade 1
9.745400E-01
Normal-vs-Grade 2
8.949600E-01
Normal-vs-Grade 3
8.352400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.435800E-01
Grade 1-vs-Grade 3
1.682810E-01
Grade 1-vs-Grade 4
9.745400E-01
Grade 2-vs-Grade 3
6.877600E-02
Grade 2-vs-Grade 4
8.949600E-01
Grade 3-vs-Grade 4
8.352400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Diabetic
4.707600E-01
Normal-vs-NonDiabetic
4.840000E-01
Diabetic-vs-NonDiabetic
7.124000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-Pancreatitis
3.271400E-01
Normal-vs-NoPancreatitis
5.051200E-01
Pancreatitis-vs-NoPancreatitis
5.051600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions
N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes
N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-N0
5.818400E-01
Normal-vs-N1
4.164400E-01
N0-vs-N1
9.575200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison
Statistical significance
Normal-vs-TP53-Mutant
9.432000E-01
Normal-vs-TP53-NonMutant
4.809600E-01
TP53-Mutant-vs-TP53-NonMutant
1.881270E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap